These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 33579349)

  • 1. Efficacy of modified Banxia Xiexin decoction in the management of Wei-Pi syndrome (postprandial distress syndrome): study protocol for a randomized, waitlist-controlled trial.
    Sin SH; Wu J; Kang Y; Yip KHK; Kong NS; Wan H; Ng BFL; Chen H
    Trials; 2021 Feb; 22(1):135. PubMed ID: 33579349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Randomized, Double-Blind, Multicenter, Placebo-Controlled Trial of Qi-Zhi-Wei-Tong Granules on Postprandial Distress Syndrome-Predominant Functional Dyspepsia.
    Su Q; Chen SL; Wang HH; Liang LX; Dai N; Lyu B; Zhang J; Wang RQ; Zhang YL; Yu Y; Liu JS; Hou XH
    Chin Med J (Engl); 2018 Jul; 131(13):1549-1556. PubMed ID: 29941708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of acupuncture versus sham acupuncture for postprandial distress syndrome: study protocol for a randomized controlled trial.
    Hou YQ; Zhang X; Tu JF; Zheng Y; Yang JW; Kim M; Hu H; Wang LQ; Zhao JJ; Zhou W; Wang J; Zou X; Wang Y; Shi GX; Liu CZ
    Trials; 2019 Jan; 20(1):65. PubMed ID: 30658669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zhizhu Kuanzhong Capsule in treating patients with functional dyspepsia postprandial distress syndrome: study protocol for a multicenter, randomized, double-blind, placebo-controlled, parallel-group clinical trial.
    Xiao M; Zhong LLD; Lam WC; Zhao Y; Gwee KA; Holtmann G; Tack J; Suzuki H; Chen MH; Xiao Y; Hou X; Liu J; Li Y; Tang XD; Lu F
    Trials; 2022 Jun; 23(1):454. PubMed ID: 35655286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Banxia Xiexin decoction alleviates AS co-depression disease by regulating the gut microbiome-lipid metabolic axis.
    Liao XX; Hu K; Xie XH; Wen YL; Wang R; Hu ZW; Zhou YL; Li JJ; Wu MK; Yu JX; Chen JW; Ren P; Wu XY; Zhou JJ
    J Ethnopharmacol; 2023 Sep; 313():116468. PubMed ID: 37044233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of Banxia Xiexin decoction for chronic atrophic gastritis: A systematic review and meta-analysis.
    Cao Y; Zheng Y; Niu J; Zhu C; Yang D; Rong F; Liu G
    PLoS One; 2020; 15(10):e0241202. PubMed ID: 33108375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acupuncture for postprandial distress syndrome (APDS): study protocol for a randomized controlled trial.
    Yang JW; Zhang LW; Shi GX; Du Y; Wang J; Zhao JJ; Cao Y; Tu JF; Zhang S; Tan C; Chen SS; Liu CZ
    Trials; 2017 Nov; 18(1):537. PubMed ID: 29132415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Traditional Banxia Xiexin decoction inhibits invasion, metastasis, and epithelial mesenchymal transition in gastric cancer by reducing lncRNA TUC338 expression.
    Dai X; Yu Y; Zou C; Pan B; Wang H; Wang S; Wang X; Wang C; Liu D; Liu Y
    Heliyon; 2023 Nov; 9(11):e21064. PubMed ID: 37964840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of Banxia Xiexin Decoction in the treatment of precancerous lesions: A protocol for systematic review and meta-analysis.
    Yi Y; Hu Z; Li R; Chen L; Zhang H; Li H; Wu M; Liu W
    Medicine (Baltimore); 2021 Apr; 100(16):e25607. PubMed ID: 33879728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of Shengjiang Xiexin decoction in prophylaxis of chemotherapy-related diarrhea in small cell lung cancer patients: study protocol for a multicenter randomized controlled trial.
    Deng C; Lou Y; Gao Y; Deng B; Su F; Jia L
    Trials; 2020 May; 21(1):370. PubMed ID: 32357899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioactive components of Banxia Xiexin Decoction for the treatment of gastrointestinal diseases based on flavor-oriented analysis.
    Wang W; Gu W; He C; Zhang T; Shen Y; Pu Y
    J Ethnopharmacol; 2022 Jun; 291():115085. PubMed ID: 35150814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of Jiu-Wei-Xi-Feng granules for treating tic disorders in children: study protocol for a randomized controlled equivalence trial.
    Guo SX; Li RB; Hu SY; Cai QH; Zhong CL; Hao RM
    Trials; 2022 Oct; 23(1):898. PubMed ID: 36273181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Banxia xiexin decoction protects against dextran sulfate sodium-induced chronic ulcerative colitis in mice.
    Chen G; Yang Y; Liu M; Teng Z; Ye J; Xu Y; Cai X; Cheng X; Yang J; Hu C; Wang M; Cao P
    J Ethnopharmacol; 2015 May; 166():149-56. PubMed ID: 25794808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of the bioactive components of Banxia Xiexin Decoction that protect against CPT-11-induced intestinal toxicity via UPLC-based spectrum-effect relationship analyses.
    Shi JW; Li ZZ; Wu JS; Jin WY; Chang XY; Sun H; Dong L; Jiang ZP; Shi Y
    J Ethnopharmacol; 2021 Feb; 266():113421. PubMed ID: 33022337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acupuncture for functional dyspepsia: study protocol for a two-center, randomized controlled trial.
    Han G; Ko SJ; Park JW; Kim J; Yeo I; Lee H; Kim SY; Lee H
    Trials; 2014 Mar; 15():89. PubMed ID: 24655542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of Gastrosis No.1 compound on functional dyspepsia of spleen and stomach deficiency-cold syndrome: a multi-center, double-blind, placebo-controlled clinical trial.
    Zhang SS; Zhao LQ; Wang HB; Wu B; Wang CJ; Huang SP; Shen H; Wei W; Lai YL
    Chin J Integr Med; 2013 Jul; 19(7):498-504. PubMed ID: 23818201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy evaluation of acupuncture combined with Liujunzi Decoction in the treatment of functional dyspepsia: A protocol of randomized controlled trial.
    Zhang Y; Bian L; Long H; Zhang W; Hu Y
    Medicine (Baltimore); 2021 Feb; 100(8):e24528. PubMed ID: 33663059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chinese herbal medicine bi min fang for allergic rhinitis: protocol for a double-blind, double-dummy, randomized controlled trial.
    Luo Q; Zhou S; Li X; Chen Q; Lin W; Lu L; Li H; Chen C; Chen W; Li Y
    Trials; 2019 Jan; 20(1):66. PubMed ID: 30658660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring the multicomponent synergy mechanism of Banxia Xiexin Decoction on irritable bowel syndrome by a systems pharmacology strategy.
    Li B; Rui J; Ding X; Yang X
    J Ethnopharmacol; 2019 Apr; 233():158-168. PubMed ID: 30590198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modified Banxia Xiexin Decoction Ameliorates Polycystic Ovarian Syndrome With Insulin Resistance by Regulating Intestinal Microbiota.
    Zhao H; Chen R; Zheng D; Xiong F; Jia F; Liu J; Zhang L; Zhang N; Zhu S; Liu Y; Zhao L; Liu X
    Front Cell Infect Microbiol; 2022; 12():854796. PubMed ID: 35619648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.